19-6444210-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP3_Moderate
The NM_024103.3(SLC25A23):c.1163C>A(p.Thr388Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,451,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T388P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_024103.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC25A23 | NM_024103.3 | c.1163C>A | p.Thr388Asn | missense_variant | 9/10 | ENST00000301454.9 | NP_077008.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC25A23 | ENST00000301454.9 | c.1163C>A | p.Thr388Asn | missense_variant | 9/10 | 1 | NM_024103.3 | ENSP00000301454.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000433 AC: 1AN: 231022Hom.: 0 AF XY: 0.00000803 AC XY: 1AN XY: 124544
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1451362Hom.: 0 Cov.: 31 AF XY: 0.00000139 AC XY: 1AN XY: 720768
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2023 | The c.1163C>A (p.T388N) alteration is located in exon 9 (coding exon 9) of the SLC25A23 gene. This alteration results from a C to A substitution at nucleotide position 1163, causing the threonine (T) at amino acid position 388 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at